Digestive Diseases and Sciences

, Volume 60, Issue 7, pp 2063–2069 | Cite as

Serologically Determined Gastric Mucosal Condition Is a Predictive Factor for Osteoporosis in Japanese Men

  • Shigeto MizunoEmail author
  • Daisuke Matsui
  • Isao Watanabe
  • Etsuko Ozaki
  • Nagato Kuriyama
  • Yoshiyuki Watanabe
Original Article



There are few reports about the influence of Helicobacter pylori infection and/or atrophic gastritis on bone conditions in Japan.


To assess whether the combination of serologically determined Helicobacter pylori infection and atrophic gastritis is available as a biomarker for bone conditions.


We studied 230 men in their 50s and 60s. Helicobacter pylori infection was determined using serum antibody to this bacterium. Atrophic gastritis was diagnosed on the basis of the serum pepsinogen I and II criteria. The characteristics of the participants’ bone were measured at the radius using an ultrasonic bone densitometry system. The risks of low trabecular bone density, low elastic modulus of trabecular bone, and low cortical thickness among subjects who were positive for Helicobacter pylori infection and/or atrophic gastritis relative to those who were not were calculated.


Helicobacter pylori infection significantly increased the risk of low trabecular bone density (odds ratio 1.83, 95 % confidence interval 1.04–3.21, P = 0.03). Atrophic gastritis significantly increased the risk of low trabecular bone density (2.22, 1.17–4.22, 0.01). Compared with anti-Helicobacter pylori antibody (−) and atrophic gastritis (−) subjects, anti-Helicobacter pylori antibody (+) and atrophic gastritis (+) subjects were a significant high-risk group for low trabecular bone density (2.65, 1.27–5.55, 0.01).


A serological diagnosis of Helicobacter pylori infection and atrophic gastritis, which is utilized for risk assessment of gastric cancer, was suggested to be useful for risk assessment of osteoporosis.


Helicobacter pylori Atrophic gastritis Osteoporosis Cohort study 



This study was supported in part by Grant-in-Aid for Scientific Research on Priority Areas of Cancer (No. 17015018), Grant-in-Aid for Scientific Research on Innovative Areas (No. 221S0001), and Grant-in-Aid for Scientific Research (C) (No. 25460233) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Conflict of interest



  1. 1.
    Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.Google Scholar
  2. 2.
    Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—“ABC method”. Proc Jpn Acad. 2011;87:405–414.CrossRefGoogle Scholar
  3. 3.
    Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109:138–143.PubMedCrossRefGoogle Scholar
  4. 4.
    Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–768.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Mizuno S, Miki I, Ishida T, et al. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci. 2010;55:3132–3137.PubMedCrossRefGoogle Scholar
  6. 6.
    Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol. 2010;45:133–138.PubMedCrossRefGoogle Scholar
  7. 7.
    Keller J, Schinke T. The role of the gastrointestinal tract in calcium homeostasis and bone remodeling. Osteoporos Int. 2013;24:2737–2748.PubMedCrossRefGoogle Scholar
  8. 8.
    Yu EW, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med. 2011;124:519–526.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Schinke T, Schilling AF, Baranowsky A, et al. Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med. 2009;15:674–681.PubMedCrossRefGoogle Scholar
  10. 10.
    Buzás GM. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol. 2014;20:5226–5234.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Figura N, Palazzuoli A, Vaira D, et al. Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide. J Clin Pathol. 2014;67:251–257.PubMedCrossRefGoogle Scholar
  12. 12.
    Nakagawa H, Tamura T, Mitsuda Y, et al. Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults. Mediators Inflamm. 2013;2013:142358.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997;41:442–451.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Figura N, Gennari L, Merlotti D, et al. Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci. 2005;50:847–852.PubMedCrossRefGoogle Scholar
  15. 15.
    Kakehasi AM, Rodrigues CB, Carvalho AV, Barbosa AJ. Chronic gastritis and bone mineral density in women. Dig Dis Sci. 2009;54:819–824.PubMedCrossRefGoogle Scholar
  16. 16.
    Ozdem S, Akcam M, Yilmaz A, Gultekin M, Artan R. Biochemical markers of bone metabolism in children with Helicobacter pylori infection. Dig Dis Sci. 2007;52:967–972.PubMedCrossRefGoogle Scholar
  17. 17.
    Kim HW, Kim YH, Han K, et al. Atrophic gastritis: a related factor for osteoporosis in elderly women. PLoS One. 2014;9:e101852.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013;7:35–40.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Wakai K, Hamajima N, Okada R, et al. Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: a project in the Japan multi-institutional collaborative cohort (J-MICC) study. J Epidemiol. 2011;21:223–235.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Kawai T, Kawakami K, Kudo T, Ogiahara S, Handa Y, Moriyasu F. A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Intern Med. 2002;41:780–783.PubMedCrossRefGoogle Scholar
  21. 21.
    Miki K, Ichinose M, Shimizu A, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn. 1987;22:133–141.PubMedGoogle Scholar
  22. 22.
    Watanabe Y, Ozasa K, Higashi A, et al. Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan. J Clin Gastroenterol. 1997;25:391–394.PubMedCrossRefGoogle Scholar
  23. 23.
    Yamamoto T, Otani T, Hagino H, et al. Measurement of human trabecular bone by novel ultrasonic bone densitometry based on fast and slow waves. Osteoporos Int. 2009;20:1215–1224.PubMedCrossRefGoogle Scholar
  24. 24.
    Sai H, Iguchi G, Tobimatsu T, et al. Novel ultrasonic bone densitometry based on two longitudinal waves: significant correlation with pQCT measurement values and age-related changes in trabecular bone density, cortical thickness, and elastic modulus of trabecular bone in a normal Japanese population. Osteoporos Int. 2010;21:1781–1790.PubMedCrossRefGoogle Scholar
  25. 25.
    Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41:452–458.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Soen S, Fukunaga M, Sugimoto T, et al. Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab. 2013;31:247–257.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Shigeto Mizuno
    • 1
    Email author
  • Daisuke Matsui
    • 2
  • Isao Watanabe
    • 2
  • Etsuko Ozaki
    • 2
  • Nagato Kuriyama
    • 2
  • Yoshiyuki Watanabe
    • 2
  1. 1.Department of Medical PharmaceuticsKobe Pharmaceutical UniversityKobeJapan
  2. 2.Department of Epidemiology for Community Health and MedicineKyoto Prefectural University of Medicine Graduate School of Medical ScienceKamigyo-kuJapan

Personalised recommendations